- Home
- PTGX vs ESE Comparison
PTGX vs ESE Comparison
Compare PTGX & ESE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | ESE |
|---|---|---|
| Founded | 2006 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.2B |
| IPO Year | 2016 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PTGX | ESE |
|---|---|---|
| Price | $92.39 | $265.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 2 |
| Target Price | $100.17 | ★ $250.00 |
| AVG Volume (30 Days) | ★ 489.3K | 219.1K |
| Earning Date | 06-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.12% |
| EPS Growth | N/A | ★ 193.15 |
| EPS | N/A | ★ 1.11 |
| Revenue | N/A | ★ $37,000,000.00 |
| Revenue This Year | $711.26 | $20.87 |
| Revenue Next Year | N/A | $6.87 |
| P/E Ratio | ★ N/A | $245.21 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $39.60 | $134.78 |
| 52 Week High | $96.54 | $291.31 |
Technical Indicators
Market Signals| Indicator | PTGX | ESE |
|---|---|---|
| Relative Strength Index (RSI) | 60.15 | 52.58 |
| Support Level | $76.63 | $198.85 |
| Resistance Level | $92.05 | $291.31 |
| Average True Range (ATR) | 3.87 | 9.12 |
| MACD | 0.79 | -2.77 |
| Stochastic Oscillator | 80.77 | 13.14 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About ESE ESCO Technologies Inc.
ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace & Defense (A&D), Utility Solutions Group (USG), and RF Test & Measurement (Test). The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure, and contain magnetic, electromagnetic, and acoustic energy.